Gift Snapshots

GIFT PROMOTES HEALING AND RECOVERY AFTER PROSTATE CANCER CARE

The William Randolph Hearst Foundation is deepening its philanthropic partnership with Houston Methodist through a generous commitment to the Urology Survivorship and Recovery Initiative Fund. This investment will further FDA-approved clinical research, including a pioneering study examining whether regenerative therapies can help preserve critical nerve pathways during prostate cancer surgery, enhancing long-term functional outcomes.

The randomized, double-blind clinical trials will evaluate the safety and potential therapeutic benefits of a stem cell-based intervention compared with standard care, focusing on protecting and restoring the neurovascular structures most at risk during radical prostatectomy. The foundation’s gift supports these researchers in their work to lessen the lasting effects of treatment, accelerate patients’ return to a high quality of life and establish new benchmarks for patient-centered recovery in prostate cancer care.

LIFESAVING NEUROSURGERY INSPIRES PAYNE FAMILY SUPPORT

Speaking of her family’s experience with Houston Methodist, Karen Payne says, “It was just a matter of a miracle.” As active members of the Houston Methodist community with an interest in neurology, Karen and her husband, Mel, were invited to hear Dr. Gavin Britz, the Candy and Tom Knudson Distinguished Centennial Chair in Neurosurgery, speak about a recent breakthrough: mechanical thrombectomy. Little did they know that a mere four days later, Dr. Britz would use that very same procedure to save Mel’s life after he suffered an ischemic stroke.

With Mel now significantly recovered, the Paynes chose to make a generous contribution to the Houston Methodist Department of Neurosurgery to help ensure brilliant physicians like Dr. Britz can continue pursuing cutting-edge research and bringing innovative procedures to their patients. In appreciation of this gift, the Interventional Radiology Family Room in Houston Methodist’s new Centennial Tower (opening in 2027) will be named the Karen and Mel Payne Family Room.

Click here to listen to the Payne's story.

A THOUGHTFUL MISSION TO ADVANCE ALZHEIMER’S RESEARCH

Gary Williams’ recent gift to the Neurology Alzheimer’s Research Fund will strengthen the work of teams studying Alzheimer’s disease at the Houston Methodist Neurological Institute. Williams, a Dallas resident, has also supported the Nantz National Alzheimer Center. His continued generosity expands the important efforts of accomplished scientists like Hyunglok Chung, PhD, and Kyuson Yun, PhD, the Houston Methodist Chair in Neurodegenerative Disease Research. Drs. Yun’s and Chung’s research spans early detection via immune and neural biomarkers and development of innovative therapeutic strategies focused on lipid metabolism, respectively. Through philanthropy, these and other Houston Methodist investigators are pushing the boundaries of how Alzheimer’s disease is detected, monitored and treated.

HONORING THE PAST, TRANSFORMING THE FUTURE OF EYE HEALTH

When Kelli and Eddy Blanton made a 2025 gift to the Blanton Eye Institute Fund, they did so with a dual purpose: to honor the legacy of Jack S. Blanton Sr. and help drive meaningful impact in ophthalmologic research and patient care. Eddy’s father, Jack, was a distinguished Houston civic leader who was instrumental in establishing the Jack S. Blanton Sr. Eye Institute. Kelli and Eddy saw this gift as the ideal method to spark broader philanthropic interest in the Blanton Eye Institute.

Their hope is that others will recognize the groundbreaking work underway at the nationally acclaimed center and join in supporting its continued growth. The institute has become a widely recognized leader in treating complex eye diseases and is one of the few programs in the country with dedicated ocular pathology services.

SMITH GIFT HIGHLIGHTS ORTHOPEDIC ADVANCES

Michelle and Alan Smith’s philanthropic investment will serve to establish the Orthopedics Research Innovation Fund within the Houston Methodist Department of Orthopedic Surgery. Alan, a former collegiate tennis player at Texas Tech University, has been following the work of Francesca Taraballi, PhD, director of the Center for Musculoskeletal Regeneration, whose research aligns closely with that of Dr. Patrick McCulloch, the John S. Dunn Chair in Orthopedic Surgery. Together, they are investigating the therapeutic potential of mesenchymal stem cells (MSCs) in treating osteoarthritis.

The Orthopedics Research Innovation Fund will support an FDA-approved clinical trial evaluating the use of MSCs as a surgical complement in anterior cruciate ligament (ACL) repair. If successful, the research team plans to expand clinical trials to assess efficacy in rotator cuff repair and, ultimately, in cartilage regeneration. The Smiths’ gift will help to catalyze the clinical trials necessary to achieve transformative progress in orthopedic care.

Discover More